Skip to content
EU comission subsidy program
Neofar IKE Company Logo
  • Home
  • About Us
    • Company Profile
    • Partners
    • Indicative Publications
      • Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
      • Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease
      • Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis
  • Fields to be Explored
    • Hypertension
    • Multiple Sclerosis
  • Services
  • Contact
  • ΕΛΛ
Menu Close
  • Home
  • About Us
    • Company Profile
    • Partners
    • Indicative Publications
      • Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
      • Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease
      • Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis
  • Fields to be Explored
    • Hypertension
    • Multiple Sclerosis
  • Services
  • Contact
  • ΕΛΛ

Hypertension

Multiple Sclerosis

Copyright NEOFAR | NewDrug IKE 2021 - OWP Powered by kataskevi-Eshop.EU